Pharmacology - Drug Development

Listings

• 

  Recombinant Human IL13 Protein

  Pharmacology - Drug Development Shirley (New York) April 28, 2019 Check with publisher

  Cytokine (PubMed:8096327, PubMed:8097324). Inhibits inflammatory cytokine production (PubMed:8096327). Synergizes with IL2 in regulating interferon-gamma synthesis (PubMed:8096327). May be critical in regulating inflammatory and immune responses (Pub...

• 

  Auditing Physician Contracts Under the New Stark Rules

  Pharmacology - Drug Development Fremont (California) March 1, 2019 Check with publisher

  Overview: In this session Mr. Wolfe will provide an overview of the Stark Law, including its recent changes. He will also discuss best practices for auditing physician compensation arrangements on behalf of health systems, hospitals, medical groups a...

• 

  Nitric Oxide Synthase Detection Kit

  Pharmacology - Drug Development Shirley (New York) February 26, 2019 Check with publisher

  Diaminofluorescein -2 Diacetate (DAF-2DA) is a non-fluorescent cell permeable reagent that can measure free Nitric Oxide (NO) and nitric oxide synthase (NOS) activity in living cells under physiological conditions. Once inside the cell the diacetate ...

• 

  ZSCAN4 peptide

  Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

  The ZSCAN4 gene encodes a protein involved in telomere maintenance and with a key role in the critical feature of mouse embryonic stem (ES) cells, namely, defying cellular senescence and maintaining normal karyotype for many cell divisions in culture...

• 

  Wnt1 peptide

  Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

  The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during em...

• 

  Fully Synthetic Carbohydrate Based Cancer Vaccines

  Pharmacology - Drug Development Shirley (New York) January 28, 2019 Check with publisher

  Malignantly transformed cells often exhibit aberrant levels and types of cell surface carbohydrates, which are typically displayed as either glycoproteins or glycosphingolipids. Through exposure of the immune system to appropriately presented tumor a...

• 

  MINA Peptide

  Pharmacology - Drug Development Shirley (New York) January 22, 2019 Check with publisher

  MINA is a c-Myc (MYC; MIM 190080) target gene that may play a role in cell proliferation or regulation of cell growth. (Tsuneoka et al., 2002 [PubMed 12091391]; Zhang et al., 2005 [PubMed 15897898]). https://www.creative-diagnostics.com/MINA-Peptide-...

• 

  Monoclonal Antibody Vaccines

  Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

  Monoclonal antibodies (mAb or moAb) are antibodies made from the same immunocytes, which are clones of a single ancestral cell. Monoclonal antibodies bind to the same epitope, so they have monovalent affinity with identical offspring of a hybridoma o...

• 

  GMP Vaccine Production

  Pharmacology - Drug Development Shirley (New York) December 26, 2018 Check with publisher

  For years, Creative Biolabs has consistently and effectively supported the vaccine industry with a unique range of products and related services. We provide process development and GMP manufacturing services to support your vaccine development and co...

• 

  VPREB3 peptide

  Pharmacology - Drug Development Shirley (New York) December 21, 2018 Check with publisher

  The protein encoded by this gene is the human homolog of the mouse VpreB3 (8HS20) protein, and is specifically expressed in cell lines representative of all stages of B-cell differentiation. It is also related to VPREB1 and other members of the immun...

• 

  US, EU and Japan GMP Requirements

  Pharmacology - Drug Development Minnesota (Minneapolis) September 5, 2018 Check with publisher

  Course "US, EU and Japan GMP Requirements: Practical ICH Area Differences, Healthcare Authority Inspection Focus " has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Descri...

• 

  Validation and 21 CFR Part 11 Compliance of Computer Systems

  Pharmacology - Drug Development Philadelphia (Pennsylvania) September 5, 2018 Check with publisher

  Course "Validation and 21 CFR Part 11 Compliance of Computer Systems" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Description: The Problem We have all heard of Compu...